Effect of filgotinib, a selective JAK 1 inhibitor, with and without methotrexate in patients with rheumatoid arthritis: patient-reported outcomes

Overview of attention for article published in Arthritis Research & Therapy, March 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 2 news outlets
twitter: 8 X users

patent: 1 patent

Citations

dimensions_citation: 42 Dimensions

Readers on

mendeley: 100 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

METHODS OF USING MOMELOTINIB TO TREAT JOINT INFLAMMATION

Application EP-4096679-A4

European Patent Office